Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR Part 50, Subpart D—Additional Safeguards for Children in Clinical Investigations
21 CFR Part 50, Subpart D—Additional Safeguards for Children in Clinical Investigations, “Additional Safeguards for Children in Clinical Investigations”, is a CFR division of 21 CFR Part 50—Protection of human subjects.
https://ontology.bommaritollc.com/id/01a0f094-b4be-763e-b7d7-ad37ddfdf28d
Elsewhere
Facts
| adms:identifier | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR Part 50, Subpart D |
| schema:legislationJurisdiction | |
| schema:legislationType | |
| schema:name | Additional Safeguards for Children in Clinical Investigationsen |
| skos:prefLabel | 21 CFR Part 50, Subpart D—Additional Safeguards for Children in Clinical Investigationsen |
Related
Parts (7)schema:isPartOf
- 21 CFR 50.50 IRB duties.
- 21 CFR 50.51 Clinical investigations not involving greater than minimal risk.
- 21 CFR 50.52 Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects.
- 21 CFR 50.53 Clinical investigations involving greater than minimal risk and no prospect of direct benefit to individual subjects, but likely to yield generalizable knowledge about the subjects' disorder or condition.
- 21 CFR 50.54 Clinical investigations not otherwise approvable that present an opportunity to understand, prevent, or alleviate a serious problem affecting the health or welfare of children.
- 21 CFR 50.55 Requirements for permission by parents or guardians and for assent by children.
- 21 CFR 50.56 Wards.